BOWEL CANCER WEST
Bowel Cancer West is dedicated to promoting research in the diagnosis and treatment of bowel cancer, education and training of the public and health professionals who care for bowel cancer patients across the West Country
Financial health, per its FY2024 accounts
The accounts state that the charity realized a small surplus of £2,301 for the year ended 31 December 2024, with unrestricted reserves increasing to £35,470. The trustees report that the charity shop was a burden on resources and has been closed, while noting that fundraising was challenging due to the cost of living crisis.
What the accounts disclose
“No employee received emoluments of more than £60,000 (2023 : None)” — page 17
Corporate structure
- Registered company of the charity Companies House 07378488
Funders the charity credits
Company officers (Companies House)
- FISHWICK, Nicola Marie on trustee list
- MENIS, Philip Stephen on trustee list
- MACKENZIE, Hugh not on trustee list
- DAVARIAN-DEHSORKHE, Sima Katie, M/S on trustee list
- BEST, John Sebastian on trustee list
- SHEPPARD, Diane Michelle on trustee list
- COLEMAN, Susan Daphne on trustee list
- COLEMAN, Mark Giles not on trustee list
Trustees
- MARK COLEMAN MD FRCSchair
- Diane Michelle Sheppard
- John Best
- Nicola Marie Fishwick
- Philip Stephen Menis
- Sima Davarian-Dehsorkhe
- Susan Coleman
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £82k | £79k |
| 31/12/2023 | £81k | £82k |
| 31/12/2022 | £88k | £85k |
| 31/12/2021 | £75k | £57k |
| 31/12/2020 | £32k | £57k |
Common questions
Is BOWEL CANCER WEST financially healthy?
Per its FY2024 accounts: The accounts state that the charity realized a small surplus of £2,301 for the year ended 31 December 2024, with unrestricted reserves increasing to £35,470. The trustees report that the charity shop was a burden on resources and has been closed, while noting that fundraising was challenging due to the cost of living crisis. Its FY2024 accounts were independently examined.